Bright Minds Biosciences Inc. (DRUG)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | — |
|
| Statements | ||
| Consolidated Statements of Financial Position | — |
|
| Consolidated Statements of Comprehensive Loss | — |
|
| Consolidated Statements of Changes In Shareholders' Equity | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Accounts Payable and Accrued Liabilities | — |
|
| Contractual Obligations | — |
|
| Financial Instruments and Capital Management | — |
|
| Income Taxes | — |
|
| Intangible Assets | — |
|
| Material Accounting Policy Information | — |
|
| Nature and Continuance of Operations | — |
|
| Note 1 | — |
|
| Note 10 | — |
|
| Note 11 | — |
|
| Note 12 | — |
|
| Note 13 | — |
|
| Note 14 | — |
|
| Note 2 | — |
|
| Note 3 | — |
|
| Note 4 | — |
|
| Note 5 | — |
|
| Note 6 | — |
|
| Note 7 | — |
|
| Note 8 | — |
|
| Note 9 | — |
|
| Premises Leases | — |
|
| Related Party Transactions | — |
|
| Research and Development | — |
|
| Share Capital | — |
|
| Significant Accounting Policies | — |
|
| Statement of Compliance and Basis of Preparation | — |
|
| Subsequent Events | — |
|